Halozyme Therapeutics Files Q1 2025 10-Q
Ticker: HALO · Form: 10-Q · Filed: May 6, 2025 · CIK: 1159036
| Field | Detail |
|---|---|
| Company | Halozyme Therapeutics, Inc. (HALO) |
| Form Type | 10-Q |
| Filed Date | May 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, royalty, product revenue
TL;DR
HALO Q1 2025 10-Q is in: check royalty & product revenue for the quarter.
AI Summary
Halozyme Therapeutics, Inc. filed its Q1 2025 10-Q report on May 6, 2025, detailing financial performance for the period ending March 31, 2025. The company, based in San Diego, CA, operates in the biological products sector and reported royalty and product revenues for the first quarter of 2025 and 2024.
Why It Matters
This filing provides investors with the latest financial snapshot of Halozyme Therapeutics, crucial for understanding revenue trends and operational performance in the biological products industry.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags.
Key Numbers
- 2025 Q1 — Reporting Period (First quarter of 2025 financial data)
- 2024-01-01 to 2024-03-31 — Prior Year Q1 Period (Comparison period for Q1 2024)
- 2025-01-01 to 2025-03-31 — Current Year Q1 Period (Reporting period for Q1 2025)
Key Players & Entities
- HALOZYME THERAPEUTICS, INC. (company) — Filer
- 20250331 (date) — Period of Report
- 20250506 (date) — Filed as of Date
- San Diego, CA (location) — Business Address
FAQ
What were Halozyme's royalty revenues for Q1 2025?
The filing indicates royalty revenues for the period January 1, 2025, to March 31, 2025.
What were Halozyme's product revenues for Q1 2025?
The filing indicates product revenues for the period January 1, 2025, to March 31, 2025.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
When was Halozyme Therapeutics, Inc. previously known as Global Yacht Services Inc?
The date of name change from Global Yacht Services Inc. was 20010912.
What is the SIC code for Halozyme Therapeutics?
The Standard Industrial Classification code is 2836, for Biological Products (No Diagnostic Substances).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 6, 2025 regarding HALOZYME THERAPEUTICS, INC. (HALO).